Education
About Us
Working with TipRanks
Follow Us
Definitive Healthcare Corp (DH)
NASDAQ:DH
DH Stock Chart & Stats
$2.39
-$0.06(-1.41%)
At close: 4:00 PM EST
$2.39
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$2.15 - $5.68
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$344.22M
Enterprise Value$517.95M
Total Cash (Recent Filing)$185.92M
Total Debt (Recent Filing)$175.40M
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Feb 19, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding103,303,390
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.08
Price to Sales (P/S)1.90
P/FCF Ratio10.46
Enterprise Value/Market Cap1.50
Enterprise Value/Revenue2.14
Enterprise Value/Gross Profit2.74
Enterprise Value/Ebitda-2.40
Forecast
1Y Price Target
$3.71Price Target Upside55.23% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
New Customer WinsAddition of net new enterprise accounts and stronger-than-expected new logo wins indicate accelerating commercial traction that could expand the customer base and support revenue upside.
Partnership ExpansionA new partnership with a go-to-market platform broadens digital marketing capabilities and creates additional channels to attract larger pharmaceutical and device customers.
Profitability LeverageStrong adjusted EBITDA performance combined with a largely fixed-cost structure positions the company to convert revenue upside into margin expansion if sales accelerate.
Bears Say
Churn And Retention RiskPersistent churn and expectations for modest net dollar retention declines during heavy renewal periods threaten revenue recovery and margin improvement.
Growth Visibility And Operating LeverageUnclear visibility on the timing of a return to positive revenue growth and anticipated margin headwinds make it difficult for the company to demonstrate operating leverage.
Sales Cycle SlowdownTighter sales cycles in the life-sciences channel are slowing deal pacing and limiting new customer growth, which pressures revenue momentum.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $2.15 and its highest was $5.68 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $344.22M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Feb 19, 2026 which is in 32 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Nov 06, 2025. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.056 by $0.014.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.06.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 103,303,390 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.07 in its last earnings report, beating expectations of $0.056. Following the earnings report the stock price went up 10.566%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.71 (55.23% Upside)
$3.71 (55.23% Upside)
Hedge Fund Trend
Increased
By 21.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-47.69%
Trailing 12-Months
Asset Growth
-45.86%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While Definitive Healthcare reported strong profitability and cash flow, as well as growth in enterprise customers and improvements in retention rates, it faced challenges with a decline in revenue and ongoing pressure in the life sciences segment. The strategic partnerships and operational efficiencies are positive indicators, but the revenue decline and macroeconomic uncertainties temper the sentiment.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$3.71
▲(55.23% Upside)
Technical Analysis
Ownership Overview
8.74% Insiders
4.81% Mutual Funds
64.30% Other Institutional Investors
16.85% Public Companies and
Individual Investors